Channel Therapeutics Corporation
CHRO · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $35,732 | $276,841 | $276,841 | $276,841 |
| - Cash | $513 | $96 | $55 | $0 |
| + Debt | $2,186 | $1,269 | $540 | $1,100 |
| Enterprise Value | $37,405 | $278,013 | $277,327 | $277,941 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$2,579 | -$392 | -$209 |
| % Margin | – | – | – | – |
| EBITDA | -$7,571 | -$6,862 | -$1,628 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$7,955 | -$7,381 | -$2,459 | -$595 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.43 | -1.28 | -0.43 | -0.1 |
| % Growth | -11.7% | -197.7% | -330% | – |
| Operating Cash Flow | -$5,792 | -$981 | -$1,567 | -$1,593 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$5,792 | -$981 | -$1,567 | -$1,593 |